Rhythm Pharmaceuticals Inc (STU:1RV)
€ 38.705 0.845 (2.23%) Market Cap: 2.43 Bil Enterprise Value: 2.24 Bil PE Ratio: 0 PB Ratio: 41.42 GF Score: 52/100

Q1 2022 Rhythm Pharmaceuticals Inc Earnings Call Transcript

May 03, 2022 / 12:30PM GMT
Release Date Price: €5.65 (+0.89%)
Operator

Welcome to the Rhythm Pharmaceuticals First Quarter 2022 Earnings Conference Call. My name is Hilda, and I will be your operator for today's call. (Operator Instructions)

I will now turn the call over to Mr. David Connolly, Investor Relations & Corporate Communications. You may begin.

David Connolly
Rhythm Pharmaceuticals, Inc. - Head of IR & Corporate Communications

Thank you, and good morning, everybody. I'm Dave Connolly, Head of IR and Corporate Communications here at Rhythm Pharmaceuticals. For those of you participating via the conference call, the accompanying slides can be accessed and controlled by going to the Events section of the Investor's page on our website at ir.rhythmtx.com.

This morning we issued a press release that provides our first quarter and first quarter 2022 financial results and business update, which is available on our website. And as listed on Slide 2, today here with me in Boston for the conference call are David Meeker, Chair, President and Chief Executive Officer of Rhythm; Jennifer Chien, Executive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot